Last reviewed · How we verify
Steroid Containing Mouthwash
DS-1062a, a steroid-containing mouthwash developed by Daiichi Sankyo, is currently in Phase 1 clinical trials for advanced solid tumors. Despite no FDA label, the drug shows promise in addressing unmet needs in oncology.
At a glance
| Generic name | Steroid Containing Mouthwash |
|---|---|
| Sponsor | Daiichi Sankyo Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Steroid Containing Mouthwash CI brief — competitive landscape report
- Steroid Containing Mouthwash updates RSS · CI watch RSS
- Daiichi Sankyo Co., Ltd. portfolio CI